Exemestane Prevents 65% of Invasive Breast Cancers in Postmenopausal Women - Internal Medicine News Digital Network Los Angeles TimesExemestane Prevents 65% of Invasive Breast Cancers in Postmenopausal WomenInternal Medicine News Digital NetworkData Source: A randomized, double-blind, placebo-controlled chemoprevention trial in 4560 postmenopausal women at risk of breast cancer. Disclosures:
Langganan:
Posting Komentar (Atom)
0 komentar:
Posting Komentar